and it plans to widen the market further now that adalimumab has been opened up to competition from cheaper rivals in europe. regional medicines optimisation committees(rmocs), which were launched last year, have been playing a pivotal role in working with nhs commissioners and providers on ...
these we should seek and act on national and local guidelines. We also have a specific responsibility to ensure that essential care continues with the minimum burden on the NHS. We must engage with those planning our local response. We may also need to work outside our specific areas of ...
Detecting changes in prescribing behaviour compared with peers can help identify missed opportunities for medicines optimisation. Automating the process of detecting these changes is necessary due to the volume of data, but challenging due to variation in prescribing volume for different measures and ...
Although a recent review has found wide variation in practice [12], the health check system is specifically designed to facilitate access to further healthcare services, increasing subsequent healthcare utilisation and providing further opportunities for appropriate screening and risk factor optimisation. ...